← back to search

Jing Jin

The University of Sydney · AU
Area of research
Cancer Research · Pathology and Forensic Medicine
Research interest
Research interests include Lymphoma Diagnosis and Treatment, Breast Cancer Treatment Studies, MicroRNA in disease regulation, and Head and Neck Cancer Studies.
h-index
37
citations
6,307
works
191
NIH funding
primary concept
Medicine
email

Recent publications

China Autism Brain Imaging Consortium: Charting Brain Growth in Chinese Children with Autism
bioRxiv (Cold Spring Harbor Laboratory) 2025cited by 4position: middledoi
Artesunate Inhibits the Development of Esophageal Cancer by Targeting HK1 to Reduce Glycolysis Levels in Areas With Zinc Deficiency
Frontiers in Oncology 2022cited by 23position: firstdoi
MiR-320b/RAD21 axis affects hepatocellular carcinoma radiosensitivity to ionizing radiation treatment through DNA damage repair signaling.
2021cited by 41position: contributordoi
A multicenter, randomized, phase III trial of short-term radiotherapy plus chemotherapy versus long-term chemoradiotherapy in locally advanced rectal cancer (STELLAR): The final reports.
Journal of Clinical Oncology 2021cited by 40position: firstdoi
Chinese expert recommendations on management of hepatocellular carcinoma during COVID-19 pandemic: a nationwide multicenter survey
HPB 2021cited by 6position: middledoi
The m6A reader YTHDF1 promotes ovarian cancer progression via augmenting EIF3C translation
Nucleic Acids Research 2020cited by 800position: middledoi
YTHDF1 Promotes Gastric Carcinogenesis by Controlling Translation of <i>FZD7</i>
Cancer Research 2020cited by 258position: middledoi
Hypofractionated Versus Conventional Fractionated Radiotherapy After Breast-Conserving Surgery in the Modern Treatment Era: A Multicenter, Randomized Controlled Trial From China
Journal of Clinical Oncology 2020cited by 111position: middledoi
Methylation-associated silencing of miR-193b improves the radiotherapy sensitivity of esophageal cancer cells by targeting cyclin D1 in areas with zinc deficiency
Radiotherapy and Oncology 2020cited by 26position: firstdoi
The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer
Cancer Communications 2019cited by 854position: middledoi
Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer: a randomised, non-inferiority, open-label, phase 3 trial
The Lancet Oncology 2019cited by 401position: middledoi
Upregulation of miR-216a exerts neuroprotective effects against ischemic injury through negatively regulating JAK2/STAT3-involved apoptosis and inflammatory pathways
Journal of neurosurgery 2018cited by 74position: middledoi
Methylation‑associated silencing of miR‑128 promotes the development of esophageal cancer by targeting COX‑2 in areas with a high incidence of esophageal cancer
International Journal of Oncology 2018cited by 18position: firstdoi
Upregulation of miR-215 exerts neuroprotection effects against ischemic injury via negative regulation of Act1/IL-17RA signaling
Neuroscience Letters 2017cited by 22position: middledoi
Research progress on the relationship between zinc deficiency, related micro<scp>RNA</scp>s, and esophageal carcinoma
Thoracic Cancer 2017cited by 21position: middledoi
Expression and prognostic value of microRNA‐26a and microRNA‐148a in gastric cancer
Journal of Gastroenterology and Hepatology 2016cited by 45position: middledoi
MAP3K1-targeting therapeutic artificial miRNA suppresses the growth and invasion of breast cancer in vivo and in vitro
SpringerPlus 2016cited by 38position: middledoi
Evaluation of miR-21 and miR-375 as prognostic biomarkers in oesophageal cancer in high-risk areas in China
Clinical & Experimental Metastasis 2016cited by 28position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Yutong He · Central South University5 papers (2016–2022)Chen Hu · Southeast University3 papers (2019–2021)Ye‐Xiong Li · Chinese Academy of Medical Sciences & Peking Union Medical College3 papers (2019–2021)Ning-Ning Lu · Chinese Academy of Medical Sciences & Peking Union Medical College2 papers (2019–2020)Guang-Yi Sun · Chinese Academy of Medical Sciences & Peking Union Medical College2 papers (2019–2020)Yong-Wen Song · Chinese Academy of Medical Sciences & Peking Union Medical College2 papers (2019–2020)Di Liang · Hebei Medical University2 papers (2016–2017)Xin-Fan Liu · Chinese Academy of Medical Sciences & Peking Union Medical College2 papers (2019–2020)Yue-Ping Liu · Chinese Academy of Medical Sciences & Peking Union Medical College2 papers (2019–2020)Shu-Lian Wang · Chinese Academy of Medical Sciences & Peking Union Medical College2 papers (2019–2020)Yong Yang · Jilin University2 papers (2019–2020)Daojuan Li · Hebei Medical University2 papers (2017–2022)Wei-Hao Wang · Chongqing University2 papers (2019–2020)Hua Ren · Shenzhen Maternity and Child Healthcare Hospital2 papers (2019–2020)Hui Fang · Shanghai Technical Institute of Electronics & Information2 papers (2019–2020)Yongdong Guo · Peking University2 papers (2018–2020)Yanmin Si · Chinese Academy of Medical Sciences & Peking Union Medical College2 papers (2020–2020)Shuan Rao · Southern Medical University2 papers (2020–2020)Jingnan Pi · Chinese Academy of Medical Sciences & Peking Union Medical College2 papers (2020–2020)Shu‐Nan Qi · Chinese Academy of Medical Sciences & Peking Union Medical College2 papers (2019–2020)